Maplight Therapeutics Common Stock Market Value
| MPLT Stock | 17.00 1.48 8.01% |
| Symbol | MapLight |
MapLight Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MapLight Therapeutics. If investors know MapLight will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MapLight Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of MapLight Therapeutics is measured differently than its book value, which is the value of MapLight that is recorded on the company's balance sheet. Investors also form their own opinion of MapLight Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is MapLight Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MapLight Therapeutics' market value can be influenced by many factors that don't directly affect MapLight Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MapLight Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if MapLight Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MapLight Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
MapLight Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to MapLight Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of MapLight Therapeutics.
| 01/21/2025 |
| 01/16/2026 |
If you would invest 0.00 in MapLight Therapeutics on January 21, 2025 and sell it all today you would earn a total of 0.00 from holding MapLight Therapeutics Common or generate 0.0% return on investment in MapLight Therapeutics over 360 days. MapLight Therapeutics is related to or competes with ProMIS Neurosciences, Edesa Biotech, Eterna Therapeutics, Biomx, BioRestorative Therapies, Immuron, and Dogwood Therapeutics. MapLight Therapeutics is entity of United States More
MapLight Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure MapLight Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess MapLight Therapeutics Common upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.33 | |||
| Information Ratio | 0.0131 | |||
| Maximum Drawdown | 38.76 | |||
| Value At Risk | (7.89) | |||
| Potential Upside | 8.62 |
MapLight Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for MapLight Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as MapLight Therapeutics' standard deviation. In reality, there are many statistical measures that can use MapLight Therapeutics historical prices to predict the future MapLight Therapeutics' volatility.| Risk Adjusted Performance | 0.0301 | |||
| Jensen Alpha | 0.0468 | |||
| Total Risk Alpha | (0.72) | |||
| Sortino Ratio | 0.0188 | |||
| Treynor Ratio | 0.1342 |
MapLight Therapeutics Backtested Returns
Currently, MapLight Therapeutics Common is somewhat reliable. MapLight Therapeutics has Sharpe Ratio of 0.0306, which conveys that the firm had a 0.0306 % return per unit of risk over the last 3 months. We have found twenty-seven technical indicators for MapLight Therapeutics, which you can use to evaluate the volatility of the firm. Please verify MapLight Therapeutics' Mean Deviation of 4.2, risk adjusted performance of 0.0301, and Downside Deviation of 4.33 to check out if the risk estimate we provide is consistent with the expected return of 0.19%. MapLight Therapeutics has a performance score of 2 on a scale of 0 to 100. The company secures a Beta (Market Risk) of 1.35, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, MapLight Therapeutics will likely underperform. MapLight Therapeutics right now secures a risk of 6.26%. Please verify MapLight Therapeutics Common jensen alpha, potential upside, as well as the relationship between the Potential Upside and daily balance of power , to decide if MapLight Therapeutics Common will be following its current price movements.
Auto-correlation | 0.00 |
No correlation between past and present
MapLight Therapeutics Common has no correlation between past and present. Overlapping area represents the amount of predictability between MapLight Therapeutics time series from 21st of January 2025 to 20th of July 2025 and 20th of July 2025 to 16th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of MapLight Therapeutics price movement. The serial correlation of 0.0 indicates that just 0.0% of current MapLight Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 0.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
MapLight Therapeutics lagged returns against current returns
Autocorrelation, which is MapLight Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting MapLight Therapeutics' stock expected returns. We can calculate the autocorrelation of MapLight Therapeutics returns to help us make a trade decision. For example, suppose you find that MapLight Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
MapLight Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If MapLight Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if MapLight Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in MapLight Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
MapLight Therapeutics Lagged Returns
When evaluating MapLight Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of MapLight Therapeutics stock have on its future price. MapLight Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, MapLight Therapeutics autocorrelation shows the relationship between MapLight Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in MapLight Therapeutics Common.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for MapLight Stock Analysis
When running MapLight Therapeutics' price analysis, check to measure MapLight Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MapLight Therapeutics is operating at the current time. Most of MapLight Therapeutics' value examination focuses on studying past and present price action to predict the probability of MapLight Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MapLight Therapeutics' price. Additionally, you may evaluate how the addition of MapLight Therapeutics to your portfolios can decrease your overall portfolio volatility.